10.32  -0.27 (-2.55%)		04-16 10:35
Open: 10.48 High: 10.51 Volume: 36,536		Pre. Close: 10.59 Low: 10.22 Market Cap: 594(M)

Short term
Mid term
Targets	6-month :	14.73	1-year :	16.67
Resists	First :	12.61	Second :	14.27
Pivot price	12
Supports	First :	9.92	Second :	8.25
MAs	MA(5) :	10.7	MA(20) :	12.18
	MA(100) :	15.71	MA(250) :	18.72
MACD	MACD :	-0.9	Signal :	-0.8
%K %D	K(14,3) :	9.5	D(3) :	7
RSI	RSI(14): 24.6
52-week	High :	32	Low :	9.92

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ EMBC ] has closed above bottom band by 7.5%. Bollinger Bands are 58.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	10.63 - 10.71	10.71 - 10.77
Low:	9.76 - 9.84	9.84 - 9.92
Close:	10.45 - 10.59	10.59 - 10.72

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

Mon, 15 Apr 2024
Allworth Financial LP Decreases Stake in Embecta Corp. (NASDAQ:EMBC) - Defense World

Sun, 14 Apr 2024
Raymond James & Associates Raises Position in Embecta Corp. (NASDAQ:EMBC) - Defense World

Tue, 09 Apr 2024
Embecta Corp. (NASDAQ:EMBC) Shares Sold by SG Americas Securities LLC - Defense World

Mon, 08 Apr 2024
Embecta (NASDAQ:EMBC) Hits New 52-Week Low at $12.13 - MarketBeat

Sat, 10 Feb 2024
Embecta Corp. (NASDAQ:EMBC) Q1 2024 Earnings Call Transcript - Yahoo Finance

Fri, 09 Feb 2024
Embecta Corp Down 8.76% To $16.20 After Earnings Beat - InvestorsObserver

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares Out	58 (M)
Shares Float	53 (M)
Held by Insiders	0.4 (%)
Held by Institutions	98.7 (%)
Shares Short	3,070 (K)
Shares Short P.Month	3,100 (K)

EPS	0.95
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-13.78
Profit Margin	4.9 %
Operating Margin	25.9 %
Return on Assets (ttm)	10.2 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0.6 %
Gross Profit (p.s.)	0
Sales Per Share	19.45
EBITDA (p.s.)	4.01
Qtrly Earnings Growth	-42.8 %
Operating Cash Flow	-6 (M)
Levered Free Cash Flow	4 (M)

PE Ratio	10.71
PEG Ratio	0
Price to Book value	-0.75
Price to Sales	0.52
Price to Cash Flow	-102.11

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.